s6y
Company name or ticker
Search
Jasper Therapeutics, Inc.
3
Ros Matthew E: Initial statement of beneficial ownership of securities
Filed
Wednesday, July 22, 2026
Period
Jul 16, 2026
Accession number
0001213900-26-080523
Documents
ownership.xml
3
POWER OF ATTORNEY
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header